Entity Common Stock, Shares Outstanding of Intra-Cellular Therapies, Inc. from 16 Jul 2013 to 10 Mar 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Intra-Cellular Therapies, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 16 Jul 2013 to 10 Mar 2025.
  • Intra-Cellular Therapies, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 10 Mar 2025 was 106,521,576, a 0.9% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Intra-Cellular Therapies, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 106,521,576 +946,721 +0.9% 10 Mar 2025 10-K/A 20 Mar 2025 2024 FY
Q3 2024 106,017,103 +9,778,977 +10% 28 Oct 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 105,666,925 +9,575,361 +10% 05 Aug 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 105,574,855 +9,649,254 +10% 03 May 2024 10-Q 07 May 2024 2024 Q1
Q3 2023 96,238,126 +1,533,072 +1.6% 31 Oct 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 96,091,564 +1,689,819 +1.8% 01 Aug 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 95,925,601 +2,331,853 +2.5% 02 May 2023 10-Q 04 May 2023 2023 Q1
Q3 2022 94,705,054 +13,241,801 +16% 01 Nov 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 94,401,745 +13,060,154 +16% 05 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 93,593,748 +12,391,522 +15% 25 Feb 2022 10-K 01 Mar 2022 2021 FY
Q3 2021 81,463,253 +1,305,699 +1.6% 05 Nov 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 81,341,591 +14,035,492 +21% 06 Aug 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 81,202,226 +15,069,043 +23% 07 May 2021 10-Q 10 May 2021 2021 Q1
Q3 2020 80,157,554 +24,896,527 +45% 06 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 67,306,099 +12,132,877 +22% 07 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 66,133,183 +11,016,444 +20% 28 Feb 2020 10-K 02 Mar 2020 2019 FY
Q3 2019 55,261,027 +534,696 +0.98% 04 Nov 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 55,173,222 +463,950 +0.85% 06 Aug 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 55,116,739 +436,287 +0.8% 25 Feb 2019 10-K 27 Feb 2019 2018 FY
Q3 2018 54,726,331 +148,705 +0.27% 07 Nov 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 54,709,272 +11,284,951 +26% 02 Aug 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 54,680,452 +11,259,974 +26% 28 Feb 2018 10-K 01 Mar 2018 2017 FY
Q3 2017 54,577,626 +11,309,383 +26% 08 Nov 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 43,424,321 +172,944 +0.4% 09 Aug 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 43,420,478 +187,826 +0.43% 09 May 2017 10-Q 10 May 2017 2017 Q1
Q3 2016 43,268,243 +245,690 +0.57% 09 Nov 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 43,251,377 +8,195,131 +23% 04 Aug 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 43,232,652 +8,304,228 +24% 28 Apr 2016 10-Q 28 Apr 2016 2016 Q1
Q3 2015 43,022,553 +13,625,384 +46% 04 Nov 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 35,056,246 +5,669,524 +19% 04 Aug 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 34,928,424 +5,705,678 +20% 11 Mar 2015 10-K 12 Mar 2015 2014 FY
Q3 2014 29,397,169 +7,262,522 +33% 31 Oct 2014 10-Q 03 Nov 2014 2014 Q3
Q2 2014 29,386,722 +24,386,722 +488% 08 Aug 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 29,222,746 15 Mar 2014 10-K 25 Mar 2014 2013 FY
Q3 2013 22,134,647 04 Nov 2013 10-Q 05 Nov 2013 2013 Q3
Q2 2013 5,000,000 16 Jul 2013 10-K 16 Jul 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.